Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
F1000Research
|
May 28, 2019
Strategies for developing and optimizing cancer vaccines
Hoyoung M Maeng, Jay A Berzofsky
Cells
|
March 29, 2023
Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics
Jihye L Golino, Xin Wang, Hoyoung M Maeng, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 23, 2025
Dendritic Cell Cancer Vaccines: Clinical Production for Cancer Immunotherapy
Hoyoung M Maeng, Purevdorj B Olkhanud, Mary Black, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 23, 2025
Dendritic Cell Cancer Vaccines: A Focused Review
Hoyoung M Maeng, Purevdorj B Olkhanud, Mary Black, et al.
Journal for Immunotherapy of Cancer
|
July 2, 2024
Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization
William Becker, Purevdorj B Olkhanud, Noriko Seishima, et al.
JCI Insight
|
August 26, 2025
Enhancing DC cancer vaccine by allogeneic MHC class II expression and Treg depletion
Noriko Seishima, William Becker, Purevdorj B Olkhanud, et al.
The Oncologist
|
January 11, 2026
The Quadruple Immunotherapy for Colorectal Cancer (QuICC) Trial for Mismatch Repair-Proficient Metastatic Colorectal Cancer
Dara Bracken-Clarke, Danielle M Pastor, Jennifer L Marté, et al.
Frontiers in Oncology
|
January 3, 2022
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy
Hoyoung M Maeng, Brittni N Moore, Hadi Bagheri, et al.
Cell Reports Methods
|
April 27, 2022
MPA<sub>PASS</sub> software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays
Joshua A Welsh, Bryce Killingsworth, Julia Kepley, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
F1000Research
|
May 28, 2019
Strategies for developing and optimizing cancer vaccines
Hoyoung M Maeng, Jay A Berzofsky
Cells
|
March 29, 2023
Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics
Jihye L Golino, Xin Wang, Hoyoung M Maeng, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 23, 2025
Dendritic Cell Cancer Vaccines: Clinical Production for Cancer Immunotherapy
Hoyoung M Maeng, Purevdorj B Olkhanud, Mary Black, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 23, 2025
Dendritic Cell Cancer Vaccines: A Focused Review
Hoyoung M Maeng, Purevdorj B Olkhanud, Mary Black, et al.
Journal for Immunotherapy of Cancer
|
July 2, 2024
Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization
William Becker, Purevdorj B Olkhanud, Noriko Seishima, et al.
JCI Insight
|
August 26, 2025
Enhancing DC cancer vaccine by allogeneic MHC class II expression and Treg depletion
Noriko Seishima, William Becker, Purevdorj B Olkhanud, et al.
The Oncologist
|
January 11, 2026
The Quadruple Immunotherapy for Colorectal Cancer (QuICC) Trial for Mismatch Repair-Proficient Metastatic Colorectal Cancer
Dara Bracken-Clarke, Danielle M Pastor, Jennifer L Marté, et al.
Frontiers in Oncology
|
January 3, 2022
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy
Hoyoung M Maeng, Brittni N Moore, Hadi Bagheri, et al.
Cell Reports Methods
|
April 27, 2022
MPA<sub>PASS</sub> software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays
Joshua A Welsh, Bryce Killingsworth, Julia Kepley, et al.
Page
of 1